Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 23911605)

1.

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP.

J Urol. 2014 Jan;191(1):40-7. doi: 10.1016/j.juro.2013.07.061. Epub 2013 Jul 30.

2.

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.

Siefker-Radtke AO, Dinney CP, Shen Y, Williams DL, Kamat AM, Grossman HB, Millikan RE.

Cancer. 2013 Feb 1;119(3):540-7. doi: 10.1002/cncr.27751. Epub 2012 Aug 22.

3.

A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.

Mitra AP, Skinner EC, Miranda G, Daneshmand S.

BJU Int. 2013 Feb;111(2):240-8. doi: 10.1111/j.1464-410X.2012.11424.x. Epub 2012 Aug 29.

PMID:
22928881
4.

Management of high-risk non-muscle invasive bladder cancer.

Brausi M, Olaru V.

Minerva Urol Nefrol. 2012 Dec;64(4):255-60. Review.

PMID:
23288212
5.

Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.

Meeks JJ, Taylor JM, Matsushita K, Herr HW, Donat SM, Bochner BH, Dalbagni G.

BJU Int. 2013 Jun;111(8):E325-30. doi: 10.1111/j.1464-410X.2012.11751.x. Epub 2013 Feb 5.

PMID:
23384236
6.

Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.

Evers PD, Logan JE, Sills V, Chin AI.

World J Urol. 2014 Apr;32(2):385-91. doi: 10.1007/s00345-013-1110-7. Epub 2013 Jun 12.

PMID:
23756991
7.

Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.

Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M, Kakehi Y; Urologic Oncology Study Group of the Japan Clinical Oncology Group.

Ann Oncol. 2014 Jun;25(6):1192-8. doi: 10.1093/annonc/mdu126. Epub 2014 Mar 24.

8.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL.

Cancer. 2007 Jul 1;110(1):62-7.

9.

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.

May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.

Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6.

PMID:
22056404
10.

Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.

Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR.

BJU Int. 2012 Sep;110(6):804-11. doi: 10.1111/j.1464-410X.2012.10939.x. Epub 2012 Feb 9.

PMID:
22321341
11.

Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.

J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.

PMID:
18801529
12.

Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.

North S, El-Gehani F, Santos C, Ghosh S, Lai R, Cass CE, Mackey JR.

J Urol. 2014 Jan;191(1):35-9. doi: 10.1016/j.juro.2013.07.006. Epub 2013 Jul 10.

PMID:
23851183
13.

Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.

Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y.

Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.

PMID:
23721764
15.

Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate.

Lavery HJ, Stensland KD, Niegisch G, Albers P, Droller MJ.

J Urol. 2014 Apr;191(4):898-906. doi: 10.1016/j.juro.2013.10.142. Epub 2013 Dec 1. Review.

PMID:
24300483
16.

Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.

May M, Helke C, Nitzke T, Vogler H, Hoschke B.

Urol Int. 2004;72(2):103-11.

PMID:
14963349
17.

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.

BJU Int. 2004 Dec;94(9):1258-62.

PMID:
15610101
18.

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.

Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.

BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26.

PMID:
23181623
19.

Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.

Khaled HM, Shafik HE, Zabhloul MS, Ghoneim M, Saber RA, Manie M, Enein HA, Megeed HA, Mansur O, Sherbini ME, Mahran TZ, Kalawee ME, Badran A, Ramadan SM.

Clin Genitourin Cancer. 2014 Oct;12(5):e233-40. doi: 10.1016/j.clgc.2014.04.002. Epub 2014 May 6.

PMID:
24889794
20.

[Radical cystectomy in the treatment of bladder cancer always in due time?].

May M, Braun KP, Richter W, Helke C, Vogler H, Hoschke B, Siegsmund M.

Urologe A. 2007 Aug;46(8):913-9. German.

PMID:
17676301
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk